Rheumatoid Arthritis with Orencia Trial Toward Sjogren's syndrome Endocrinopathy (ROSE II Trial)
Not Applicable
Completed
- Conditions
- Rheumatoid Arthritis complicated with Sjogren's syndrome
- Registration Number
- JPRN-UMIN000016273
- Lead Sponsor
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 68
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with contraindication for abatacept 2) Aged 75 and more than 75 years old 3) Patients with leukopenia (leukocyte count<=3000) and positive for B-D Glucan 4) Patients who are pregnant, nursing, want to get pregnant 5) Aged less than 20 years old 6) Patients who are treated with palliative therapies for dryness including cevimeline, anetholtritione, and pilocarpine within the last 4 weeks 7) Patients with severe liver or kidney diseases, severe hematological disorders 8) Patients with negative for both anti-SS-A and SS-B antibody and positive for anti-centromere antibody 9) Patients who are considered not suitable for this study by the attending physicians
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method